[{"id":"6621b1d7-f94f-4b63-b32f-3acc54426d6b","acronym":"","url":"https://clinicaltrials.gov/study/NCT05681650","created_at":"2023-01-12T15:02:17.858Z","updated_at":"2024-07-02T16:35:26.470Z","phase":"Phase 1/2","brief_title":"HER2 Targeted HypoSti.CAR-T Cells in HER2 Positive Advanced Solid Tumors","source_id_and_acronym":"NCT05681650","lead_sponsor":"Chinese PLA General Hospital","biomarkers":" HER-2","pipe":" | ","alterations":" HER-2 expression","tags":["HER-2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HER-2 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e albumin-bound paclitaxel • cyclophosphamide • fludarabine IV • HypoSti.CAR-HER2 T"],"overall_status":"Recruiting","enrollment":" Enrollment 30","initiation":"Initiation: 10/11/2023","start_date":" 10/11/2023","primary_txt":" Primary completion: 12/31/2025","primary_completion_date":" 12/31/2025","study_txt":" Completion: 12/31/2026","study_completion_date":" 12/31/2026","last_update_posted":"2023-12-12"}]